JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹3.24 Cr | ₹0.47 Cr | ₹-1.37 Cr | ₹2.54 Cr | ₹-0.04 Cr |
What is the latest Net Cash Inflow / Outflow ratio of JENBURKT PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹3.24 Cr |
| Mar2024 | ₹0.47 Cr |
| Mar2023 | ₹-1.37 Cr |
| Mar2022 | ₹2.54 Cr |
| Mar2021 | ₹-0.04 Cr |
How is Net Cash Inflow / Outflow of JENBURKT PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.24 Cr | 596.56 | |
| Mar2024 | ₹0.47 Cr | Positive | |
| Mar2023 | ₹-1.37 Cr | Negative | |
| Mar2022 | ₹2.54 Cr | Positive | |
| Mar2021 | ₹-0.04 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹484.8 Cr | 1% | -5.4% | -19% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 1% |
-5.4% |
-19% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses